USE OF TISSUE-PLASMINOGEN ACTIVATOR FOR REOPENING OF CLOTTED DIALYSIS CATHETERS

被引:38
|
作者
PAULSEN, D
REISAETHER, A
AASEN, M
FAUCHALD, P
机构
[1] Medical Department B, National Hospital of Norway, N-0027 Oslo-1
来源
NEPHRON | 1993年 / 64卷 / 03期
关键词
HEMODIALYSIS; CENTRAL VENOUS CATHETERS; FIBRINOLYTIC AGENTS; TISSUE PLASMINOGEN ACTIVATOR;
D O I
10.1159/000187374
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The use of central venous catheters as permanent vascular access in chronic hemodialysis is complicated by clotting. We have tried a nonallergenic thrombolytic agent, tissue plasminogen activator (t-PA), to dissolve catheter luminal thrombosis. Eight patients, 7 in chronic hemodialysis and 1 treated by immune adsorption had 18 treatments with locally applied t-PA (2 mg/2 cm3). Fifteen out of 16 treatments with longer bolus dwell than 60 min were successful. No side effects occurred. t-PA dissolves clot formation efficiently and safely, the drug is nonallergenic and can therefore be given repeatedly.
引用
收藏
页码:468 / 470
页数:3
相关论文
共 50 条
  • [41] FLUORESCEIN LABELING OF TISSUE-PLASMINOGEN ACTIVATOR FOR SUBRETINAL THROMBOLYSIS
    SCHNEIDERMAN, TE
    JOHNSON, MW
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1995, 120 (06) : 797 - 798
  • [42] EFFECT OF DDAVP ON THE RELEASE OF TISSUE-PLASMINOGEN ACTIVATOR (TPA) AND TISSUE-PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1) FROM ENDOTHELIAL-CELLS
    HASHEMI, S
    AYE, MT
    TRUDEL, E
    COUTURE, C
    PALMER, DS
    BLOOD, 1994, 84 (10) : A76 - A76
  • [43] A NEW VARIANT OF TISSUE-PLASMINOGEN ACTIVATOR WITH ENHANCED EFFICACY AND LOWER INCIDENCE OF BLEEDING WHEN COMPARED TO RECOMBINANT HUMAN TISSUE-PLASMINOGEN ACTIVATOR (ACTIVASE)
    BENEDICT, CR
    REFINO, C
    KEYT, B
    PAONI, N
    TODD, J
    PATER, C
    BADILLO, J
    THOMAS, R
    BENNETT, W
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A314 - A314
  • [44] TISSUE-PLASMINOGEN ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITOR AND RISK OF PERIPHERAL ARTERIAL-DISEASE
    SMITH, FB
    LEE, AJ
    RUMLEY, A
    FOWKES, FGR
    LOWE, GDO
    ATHEROSCLEROSIS, 1995, 115 (01) : 35 - 43
  • [45] Thrombolysis of clotted hemodialysis grafts with tissue-type plasminogen activator
    Falk, A
    Mitty, H
    Guller, J
    Teodorescu, V
    Uribarri, J
    Vassalotti, J
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2001, 12 (03) : 305 - 311
  • [46] Alteplase (TPA) for clotted dialysis catheters
    Hathiwala, SC
    Hristea, I
    Khalili, V
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2000, 23 (10): : 668 - 669
  • [47] SUCCESSFUL TREATMENT OF VENOOCCLUSIVE DISEASE WITH RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR IN A PATIENT REQUIRING PERITONEAL-DIALYSIS
    SIMPSON, DR
    BROWETT, PJ
    DOAK, PB
    PALMER, SJ
    BONE MARROW TRANSPLANTATION, 1994, 14 (04) : 635 - 636
  • [48] Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation
    Bobbink, IWG
    Tekelenburg, WLH
    Sixma, JJ
    deBoer, HC
    Banga, JD
    deGroot, PG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 240 (03) : 595 - 601
  • [49] TISSUE-PLASMINOGEN ACTIVATOR, PLASMINOGEN-ACTIVATOR INHIBITORS, AND ACTIVATOR-INHIBITOR COMPLEX IN LIVER-DISEASE
    LEIPER, K
    CROLL, A
    BOOTH, NA
    MOORE, NR
    SINCLAIR, T
    BENNETT, B
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (03) : 214 - 217
  • [50] THE EFFECTS OF VARIABLE GLYCOSYLATION ON THE FUNCTIONAL ACTIVITIES OF RIBONUCLEASE, PLASMINOGEN AND TISSUE-PLASMINOGEN ACTIVATOR
    RUDD, PM
    WOODS, RJ
    WORMALD, MR
    OPDENAKKER, G
    DOWNING, AK
    CAMPBELL, ID
    DWEK, RA
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1248 (01): : 1 - 10